Been digging through some older market research and found something worth revisiting. Back in 2022-2023, when everyone was worried about recession and looking for safe bets, there was actually a solid opportunity hiding in plain sight: quality monthly dividend stocks under $5. The idea was simple but effective - get meaningful yield without breaking the bank on share price.

Let me walk through what caught analysts' attention back then. The broader dividend stock category had been outperforming, especially when you factored in reinvestment. CIBC Asset Management showed dividend stocks with reinvestments returning 10.62% over a 15-year period through mid-2021. Not bad for "boring" dividend plays.

B2Gold was one that kept popping up. The Canadian gold miner was producing steady ounces - hit 223,623 ounces in Q2 that year - while managing to keep costs in check despite inflation. Stock was down about 4.3% year-to-date at that point but yielding 4.6%. Wall Street was pretty bullish, with a Strong Buy consensus and average price target around $5.81. For dividend stocks under $5, that kind of upside made sense.

Then there was Diversified Healthcare Trust, trading around $1 but offering roughly 4% yield. The company owned healthcare properties across 36 states, which sounds stable until you factor in the operational headwinds - Q3 hit them with $4.1 million in extra costs from inflation and wage pressure. Still managed to grow net income almost 9% year-over-year though. Analysts were moderately bullish with a $4.50 price target.

New York Mortgage Trust was the yield monster - 14.4% dividend yield on a stock trading under $3. Real estate market was rough back then, but the company kept its balance sheet clean and had been consistently paying distributions. That kind of yield on affordable dividend stocks definitely caught attention, even with the risk factor.

Kinross Gold showed a classic pattern. Started 2022 strong, got beat up mid-year, then climbed back as they announced increased buybacks. Yielding 3% with earnings of $82.3 million, they'd managed to boost production while cutting costs and divesting Russian assets. Strong Buy rating from analysts with $5.32 target.

Aegon N.V., the Dutch insurance and asset management company, was quietly up 2% for the year with a 4.2% yield on shares trading just under $5. Cash position improved 8.7% year-over-year, which showed solid financial positioning. Moderate Buy consensus with $5.47 target.

The common thread across all these monthly dividend stocks under $5 was the same: they offered real yield at reasonable prices when the market was spooked. Not flashy, not going to make you rich quick, but the kind of holdings that actually cushion a portfolio when things get messy. Analysts across the board saw 20-30% upside in most of these names, which paired with the current yields made for decent risk-reward at the time.

Worth noting that this was a specific moment in the market cycle - late 2022 when volatility was elevated and yield-seeking was in favor. These kinds of opportunities come and go, but the principle still holds: sometimes the best long-term returns hide in the unsexy dividend plays that nobody's talking about.